Microscopic versus endoscopic transsphenoidal surgery in the Leiden cohort treated for Cushing's disease: surgical outcome, mortality, and complications

• Published in: Orphanet journal of rare diseases 2019-03, Vol.14 (1), p.64-15, Article 64
• Main Authors: Broersen, Leonie H A, van Haalen, Femke M, Biermasz, Nienke R, Lobatto, Daniel J, Verstegen, Marco J T, van Furth, Wouter R, Dekkers, Olaf M, Pereira, Alberto M
• Format: Article
• Language: English
• Subjects: Adenoma; Adolescent; Adrenocorticotropic hormone; Adult; Aged; Aged, 80 and over; Analysis; Care and treatment; Child; Cohort Studies; Complications; Cushing syndrome; Cushing's disease; Disease-Free Survival; Endoscopy; Endoscopy - standards; Female; Humans; Magnetic Resonance Imaging; Male; Medical centers; Medical research; Microscopy; Microsurgery; Middle Aged; Mortality; Nervous system diseases; Netherlands; Neurosurgery; Patients; Physicians; Pituitary; Pituitary ACTH Hypersecretion - diagnostic imaging; Pituitary ACTH Hypersecretion - mortality; Pituitary ACTH Hypersecretion - surgery; Rare diseases; Recurrence; Remission; Risk factors; Studies; Surgery; Surgical outcome; Surgical outcomes; Survival; Systematic review; Transsphenoidal adenomectomy; Treatment Outcome; Tumors; Young Adult
• ISSN: 1750-1172; 1750-1172
• DOI: 10.1186/s13023-019-1038-0

First-choice treatment for Cushing's disease is transsphenoidal adenomectomy. Since its introduction in the 1970s, many centers have now switched from microscopic to endoscopic surgery. We compared both techniques for the treatment of Cushing's disease at the Leiden University Medical Center, a European reference center for pituitary diseases. Cohort study with inclusion and follow-up of consecutive Cushing's disease patients primarily treated by transsphenoidal surgery at the Leiden University Medical Center between 1978 and 2016. We compared remission rates (primary endpoint), mortality, and complications between microscopic (performed up to 2005) and endoscopic (performed from 2003 onwards) surgery. Subgroup analyses were performed by tumor size, surgical experience, and preoperative imaging techniques. Additionally, surgeons' intraoperative findings regarding presence and removal of the adenoma were related to surgical outcome. Of 137 included patients, 87 were treated microscopically and 50 endoscopically. Three months after microscopic surgery, 74 patients (86%) were in remission. Five-year recurrence-free survival was 89% (95% confidence interval [CI]: 82-96%), and ten-year recurrence free survival was 84% (95% CI: 75-93%). After endoscopic surgery, 39 patients (83%) were in remission. Both five-year and ten-year recurrence-free survival were 71% (95% CI: 55-87%). Hazard ratio for recurrence was 0.47 (95% CI: 0.19-1.14), and for mortality 2.79 (95% CI: 0.35-22.51), for microscopic versus endoscopic surgery. No learning curve was found for endoscopy, nor an influence of preoperative imaging technique for microscopy. In addition, we did not find a clear relation between the surgeons' intraoperative findings and surgical outcomes. This study did not identify a clear advantage of microscopic or endoscopic transsphenoidal surgery for the treatment of Cushing's disease based on clinical outcome. The transition to endoscopic surgery at our center was not accompanied by transient worsening of outcomes, which may be reassuring for those considering transitioning.